Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$42.56 - $59.82 $119,721 - $168,273
-2,813 Reduced 65.62%
1,474 $83,000
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $74,456 - $157,186
-2,337 Reduced 35.28%
4,287 $185,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $1.09 Million - $1.77 Million
-23,902 Reduced 78.3%
6,624 $435,000
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $140,601 - $275,157
3,397 Added 12.52%
30,526 $1.37 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $94,212 - $147,256
-1,302 Reduced 4.58%
27,129 $1.96 Million
Q2 2022

Aug 08, 2022

BUY
$87.2 - $114.05 $1.27 Million - $1.66 Million
14,547 Added 104.78%
28,431 $3.05 Million
Q1 2022

May 10, 2022

BUY
$94.19 - $124.49 $1.31 Million - $1.73 Million
13,884 New
13,884 $1.54 Million
Q4 2021

Feb 11, 2022

SELL
$119.57 - $139.07 $748,149 - $870,160
-6,257 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$109.17 - $142.35 $917,792 - $1.2 Million
-8,407 Reduced 57.33%
6,257 $833,000
Q2 2021

Aug 09, 2021

SELL
$100.34 - $115.69 $298,611 - $344,293
-2,976 Reduced 16.87%
14,664 $1.59 Million
Q1 2021

Apr 28, 2021

BUY
$101.51 - $125.27 $1.77 Million - $2.18 Million
17,434 Added 8463.11%
17,640 $1.86 Million
Q4 2020

Feb 09, 2021

SELL
$85.88 - $105.36 $1.63 Million - $2 Million
-18,963 Reduced 98.93%
206 $21,000
Q3 2020

Nov 02, 2020

SELL
$72.74 - $92.5 $99,508 - $126,540
-1,368 Reduced 6.66%
19,169 $1.64 Million
Q2 2020

Aug 11, 2020

SELL
$48.02 - $79.04 $398,277 - $655,557
-8,294 Reduced 28.77%
20,537 $1.51 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $654,864 - $1.12 Million
17,723 Added 159.55%
28,831 $1.5 Million
Q4 2019

Feb 13, 2020

SELL
$47.06 - $56.64 $953,482 - $1.15 Million
-20,261 Reduced 64.59%
11,108 $624,000
Q3 2019

Oct 17, 2019

BUY
$47.45 - $58.05 $302,351 - $369,894
6,372 Added 25.49%
31,369 $1.49 Million
Q2 2019

Aug 05, 2019

BUY
$39.26 - $54.21 $68,587 - $94,704
1,747 Added 7.51%
24,997 $1.36 Million
Q1 2019

Apr 16, 2019

SELL
$29.84 - $43.92 $232,304 - $341,917
-7,785 Reduced 25.08%
23,250 $945,000
Q4 2018

Jan 17, 2019

BUY
$29.95 - $46.34 $416,814 - $644,913
13,917 Added 81.3%
31,035 $967,000
Q3 2018

Nov 02, 2018

SELL
$40.12 - $45.55 $122,285 - $138,836
-3,048 Reduced 15.11%
17,118 $0
Q2 2018

Jul 24, 2018

BUY
$38.72 - $42.52 $466,808 - $512,621
12,056 Added 148.66%
20,166 $0
Q1 2018

May 03, 2018

SELL
$39.4 - $47.39 $52,599 - $63,265
-1,335 Reduced 14.13%
8,110 $333,000
Q4 2017

Feb 02, 2018

BUY
$37.27 - $43.02 $45,394 - $52,398
1,218 Added 14.8%
9,445 $388,000
Q3 2017

Oct 20, 2017

BUY
$33.75 - $41.67 $277,661 - $342,819
8,227
8,227 $328,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.